Key result
Amiodarone and acetazolamide achieve sustained remission in a severe case of Andersen syndrome.
Why the study?
Therapeutic options for life-threatening cardiac dysrhythmias in Andersen syndrome are limited.
Does treatment with amiodarone and acetazolamide improve symptoms and prevent arrhythmias in a patient with severe Andersen syndrome?
Case Report (n=1)
Does treatment with amiodarone and acetazolamide improve symptoms and prevent arrhythmias in a patient with severe Andersen syndrome?
Amiodarone and acetazolamide may be an effective therapeutic option for managing life-threatening ventricular tachyarrhythmias and periodic paralysis in severe Andersen syndrome.
Answers are grounded in this paper and cite their sources.
May support amiodarone-acetazolamide in refractory Andersen syndrome; hypothesis-generating case report leaves open need for controlled trials.
Andersen syndrome (AS) is characterized by the triad of periodic paralysis, ventricular tachyarrhythmias, and distinctive morphologic features. The cardiac dysrhythmias are often life-threatening but therapeutic options are limited.1-4⇓⇓⇓ Genetic studies recently identified nine different point mutations in KCNJ2 encoding the inward rectifying potassium channel Kir2.1.5 We describe a severely affected patient in whom treatment with amiodarone and acetazolamide resulted in sustained remission. A now 18-year-old woman with negative family history first developed symptoms at the age of 6 with recurrent flaccid paresis. At 10 years, a poststreptococcal myocarditis was suggested because of elevated serum creatine kinase levels of up to 447 U/L and asymptomatic polymorphic ventricular premature beats on EKG. Because weakness remitted spontaneously, a psychogenic origin was suspected. At age 15, she required cardiopulmonary resuscitation because of ventricular fibrillation. By programmed electrical stimulation sustained ventricular tachyarrhythmias were inducible. The QTc interval was slightly prolonged with 0.45 seconds.
No takes yet. Share an insight, caveat, or question.
Junker et al. (2002) conducted a case report in Andersen syndrome (n=1). Amiodarone and acetazolamide was evaluated on Sustained remission. Treatment with amiodarone and acetazolamide resulted in sustained remission in a severely affected 18-year-old woman with genetically confirmed Andersen syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: